Epidémie de Mpox
The World Health Organization (WHO) first named mpox a public health concern in the summer of 2022. While the initial spike in cases was tempered by widespread vaccination, the original strain of the virus has continued to circulate with a rise in cases recently detected in Ontario. In mid-August, the WHO once again declared mpox a global public health emergency following an outbreak of the virus in parts of Africa. The new strain of the virus has not been detected in Canada. The CTN+ study PLATINUM-CAN is evaluating the effectiveness and safety of tecovirimat for the treatment of mpox in Montreal, Toronto, and Vancouver.
